rs137854488
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_212482.4(FN1):c.2918A>G(p.Tyr973Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_212482.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glomerulopathy with fibronectin deposits 2 Pathogenic:3
- -
A heterozygous missense variant, NM_212482.3(FN1):c.2918A>G, has been identified in exon 19 of 46 of the FN1 gene (NB: This variant is non-coding in alternative transcripts). The variant is predicted to result in a major amino acid change from tyrosine to cysteine at position 973 of the protein (NP_997647.1(FN1):p.(Tyr973Cys)). The tyrosine residue at this position has very high conservation (100 vertebrates, UCSC), and is located within the Hep III heparin-binding domain (Castelletti, F., et al. (2008)) and fibronectin type III functional domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is absent in the gnomAD population database. The variant has been previously described as pathogenic and segregated with disease in multiple families with glomerulopathy with fibronectin deposits (ClinVar, Ohtsubo, H., et al. (2016), Ertoy Baydar, D., et al. (2013)). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC. -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.96 (>=0.6, sensitivity 0.68 and specificity 0.92)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000016325 /PMID: 18268355). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 27056061). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Spondylometaphyseal dysplasia - Sutcliffe type;C1866075:Glomerulopathy with fibronectin deposits 2 Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 973 of the FN1 protein (p.Tyr973Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with glomerulopathy with fibronectin deposits (PMID: 18268355, 32939031). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16325). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. -
FN1-related disorder Pathogenic:1
The FN1 c.2918A>G variant is predicted to result in the amino acid substitution p.Tyr973Cys. This variant has been reported in multiple individuals with glomerulopathy with fibronectin deposits and segregated with the disease in at least one family (see for example, Castelletti et al 2008. PubMed ID: 18268355; Jayasinghe et al 2020. PubMed ID: 32939031). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at